Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus

Author： Derosa Giuseppe Salvadeo Sibilla AT Cicero Arrigo FG

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.5, 2006-09, pp. : 559-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial

By Farsang Csaba

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 333-344

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US

By Lee W.C. Conner C. Hammer M.

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 897-906

Informa Healthcare

Access to resources Recommend Favorite

A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes

By Hutchins Valerie Zhang Bin Fleurence Rachael L. Krishnarajah Girishanthy Graham John

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1157-1168

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus

By Guo Xiao-hui Lv Xiao-feng Han Ping Zhang Xiu-zhen Yang Hua-zhang Duan Wen-ruo Gao Yan

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 169-174

Informa Healthcare

Access to resources Recommend Favorite

Fixed-dose single tablet combinations: an alternative for initial therapy of patients with Type 2 diabetes?

By Zhang Wei Xing Shan-Shan Wang Huan-Jun Xing Qi-Chong

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2321-2322

Informa Healthcare

Access to resources Recommend Favorite